Testing for mismatch repair deficiency remains underused among adults with colorectal cancer, despite the existence of well-established guidelines aimed at high-risk populations. READ MORE
In patients with non-metastatic renal cell carcinoma, intentional lymph node dissection at the time of resection of the primary tumor appears to confer no benefit.
Several factors should be considered when deciding whether or not hepatectomy is justified for patients with RAS-mutant colorectal liver metastases.
Research in Review
Expression of epidermal growth factor receptor ligands epiregulin and amphiregulin may help determine which patients with colorectal cancer are the most likely to benefit from panitumumab therapy.
Mutations of the BRAF and KRAS genes may be associated with worse outcomes in certain patients with colon cancer, according to a new study.